WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 1.9% of their position (3K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $6.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/18/2023ACC: 0001213900-23-041179
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+3K
Net shares
Net buyer
$6.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$2.06
Trade value
$5.15K
% of position
1.6%
5/17/2023
154.72K→157.22K
Common Stock
Direct
Shares
+500.00
Price / share
$2.11
Trade value
$1.05K
% of position
0.3%
5/18/2023
157.22K→157.72K
Total
Net shares
+3K
Net value
$6.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2023 | P · Purchase | +2.50K | $2.06 | $5.15K | 1.6% | 154.72K | 157.22K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +500.00 | $2.11 | $1.05K | 0.3% | 157.22K | 157.72K |
| Total | +3K | $6.20K | ||||||
Derivative Transactions0
No derivative transactions reported